Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Address
2450 HOLCOMBE BLVD
HOUSTON, TX 77021
Founded
1991
Number of Employees
8
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)